Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.

NCT04558892 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Stopped The primary objectives were achieved.

Conditions

Nephrotic Syndrome

Interventions

DRUG: Enoxaparin

Sponsor

Military Institute od Medicine National Research Institute